The pharmacological use of ellagic acid-rich pomegranate fruit

References

• Afaq F, Saleem M, Krueger CG, Reed JD, Mukhtar H. 2005. Anthocyanin- and hydrolyzable tannin-rich pomegranate fruit extract modulates MAPK and NF-kappaB pathways and inhibits skin tumorigenesis in CD-1 mice. Int J Cancer 113:423–433
   PubMed Web of Science ®Google Scholar
• Anderson KJ, Teuber SS, Gobeille A, Cremin P, Waterhouse AL, Steinberg FM. 2001. Walnut polyphenolics inhibit in vitro human plasma and LDL oxidation. J Nutr 131:2837–2842
   PubMed Web of Science ®Google Scholar
• Aviram M. 2012. Atherosclerosis: cell biology and lipoproteins – paraoxonases protect against atherosclerosis and diabetes development. Curr Opin Lipidol 23:169–171
   PubMedGoogle Scholar
• Aviram M, Rosenblat M. 2012. Pomegranate protection against cardiovascular diseases. Evid Based Complement Alternat Med 2012:382763
   PubMed Web of Science ®Google Scholar
• Aviram M, Rosenblat M, Gaitini D, Nitecki S, Hoffman A, Dornfeld L, Volkova N, et al. 2004. Pomegranate juice consumption for 3 years by patients with carotid artery stenosis reduces common carotid intima-media thickness, blood pressure and LDL oxidation. Clin Nutr 23:423–433
   PubMed Web of Science ®Google Scholar
• Aviram M, Volkova N, Coleman R, Dreher M, Reddy MK, Ferreira D, Rosenblat M. 2008. Pomegranate phenolics from the peels, arils, and flowers are antiatherogenic: studies in vivo in atherosclerotic apolipoprotein e-deficient (E 0) mice and in vitro in cultured macrophages and lipoproteins. J Agric Food Chem 56:1148–1157
   PubMed Web of Science ®Google Scholar
• Bagri P, Ali M, Aeri V, Bhowmik M, Sultana S. 2009. Antidiabetic effect of Punica granatum flowers: effect on hyperlipidemia, pancreatic cells lipid peroxidation and antioxidant enzymes in experimental diabetes. Food Chem Toxicol 47:50–54
   PubMed Web of Science ®Google Scholar
• Bala I, Bhardwaj V, Hariharan S, Kumar MN. 2006. Analytical methods for assay of ellagic acid and its solubility studies. J Pharm Biomed Anal 40:206–210
   PubMed Web of Science ®Google Scholar
• Chen C, Yu R, Owuor ED, Kong AN. 2000. Activation of antioxidant-response element (ARE), mitogen-activated protein kinases (MAPKs) and caspases by major green tea polyphenol components during cell survival and death. Arch Pharm Res 23:605–612
   PubMed Web of Science ®Google Scholar
• Constantinou A, Stoner GD, Mehta R, Rao K, Runyan C, Moon R. 1995. The dietary anticancer agent ellagic acid is a potent inhibitor of DNA topoisomerases in vitro. Nutr Cancer 23:121–130
   PubMed Web of Science ®Google Scholar
• Corbett S, Daniel J, Drayton R, Field M, Steinhardt R, Garrett N. 2010. Evaluation of the anti-inflammatory effects of ellagic acid. J Perianesth Nurs 25:214–220
   PubMed Web of Science ®Google Scholar
• Cozzi R, Ricordy R, Bartolini F, Ramadori L, Perticone P, De Salvia R. 1995. Taurine and ellagic acid: two differently-acting natural antioxidants. Environ Mol Mutagen 26:248–254
   PubMed Web of Science ®Google Scholar
• de Nigris F, Balestrieri ML, Williams-Ignarro S, D'Armiento FP, Fiorito C, Ignarro LJ, Napoli C. 2007. The influence of pomegranate fruit extract in comparison to regular pomegranate juice and seed oil on nitric oxide and arterial function in obese Zucker rats. Nitric Oxide 17:50–54
   PubMed Web of Science ®Google Scholar
• Devipriya N, Srinivasan M, Sudheer AR, Menon VP. 2007a. Effect of ellagic acid, a natural polyphenol, on alcohol-induced prooxidant and antioxidant imbalance: a drug dose dependent study. Singapore Med J 48:311–318
   PubMedGoogle Scholar
• Devipriya N, Sudheer AR, Menon VP. 2007b. Dose-response effect of ellagic acid on circulatory antioxidants and lipids during alcohol-induced toxicity in experimental rats. Fundam Clin Pharmacol 21:621–630
   PubMed Web of Science ®Google Scholar
• Doyle B, Griffiths LA. 1980. The metabolism of ellagic acid in the rat. Xenobiotica 10:247–256
   PubMed Web of Science ®Google Scholar
• Edderkaoui M, Odinokova I, Ohno I, Gukovsky I, Go VL, Pandol SJ, Gukovskaya AS. 2008. Ellagic acid induces apoptosis through inhibition of nuclear factor kappa B in pancreatic cancer cells. World J Gastroenterol 14:3672–3680
   PubMed Web of Science ®Google Scholar
• Eisenberg DM, Davis RB, Ettner SL, Appel S, Wilkey S, Van Rompay M, Kessler RC. 1998. Trends in alternative medicine use in the United States, 1990–1997: results of a follow-up national survey. JAMA 280:1569–1575
   PubMed Web of Science ®Google Scholar
• Espín JC, García-Conesa MT, Tomás-Barberán FA. 2007. Nutraceuticals: facts and fiction. Phytochemistry 68:2986–3008
   PubMed Web of Science ®Google Scholar
• Falsaperla M, Morgia G, Tartarone A, Ardito R, Romano G. 2005. Support ellagic acid therapy in patients with hormone refractory prostate cancer (HRPC) on standard chemotherapy using vinorelbine and estramustine phosphate. Eur Urol 47:449–454; discussion 454–445
   PubMed Web of Science ®Google Scholar
• Feresin GE, Tapia A, Gutierrez RA, Delporte C, Backhouse Erazo N, Schmeda-Hirschmann G. 2002. Free radical scavengers, anti-inflammatory and analgesic activity of Acaena magellanica. J Pharm Pharmacol 54:835–844
   PubMedGoogle Scholar
• Fuhrman B, Volkova N, Aviram M. 2010. Pomegranate juice polyphenols increase recombinant paraoxonase-1 binding to high-density lipoprotein: studies in vitro and in diabetic patients. Nutrition 26:359–366
   PubMed Web of Science ®Google Scholar
• Furlanetto V, Zagotto G, Pasquale R, Moro S, Gatto B. 2012. Ellagic acid and polyhydroxylated urolithins are potent catalytic inhibitors of human topoisomerase II: an in vitro study. J Agric Food Chem 60:9162–9170
   PubMed Web of Science ®Google Scholar
• Gainok J, Daniels R, Golembiowski D, Kindred P, Post L, Strickland R, Garrett N. 2011. Investigation of the anti-inflammatory, antinociceptive effect of ellagic acid as measured by digital paw pressure via the Randall-Selitto meter in male Sprague-Dawley rats. AANA J 79:S28–S34
   PubMedGoogle Scholar
• Giménez-Bastida JA, González-Sarrías A, Larrosa M, Tomás-Barberán F, Espín JC, García-Conesa MT. 2012a. Ellagitannin metabolites, urolithin A glucuronide and its aglycone urolithin A, ameliorate TNF-α-induced inflammation and associated molecular markers in human aortic endothelial cells. Mol Nutr Food Res 56:784–796
   PubMed Web of Science ®Google Scholar
• Giménez-Bastida JA, Larrosa M, González-Sarrías A, Tomás-Barberán F, Espín JC, García-Conesa MT. 2012b. Intestinal ellagitannin metabolites ameliorate cytokine-induced inflammation and associated molecular markers in human colon fibroblasts. J Agric Food Chem 60:8866–8876
   PubMed Web of Science ®Google Scholar
• Hassoun EA, Vodhanel J, Abushaban A. 2004. The modulatory effects of ellagic acid and vitamin E succinate on TCDD-induced oxidative stress in different brain regions of rats after subchronic exposure. J Biochem Mol Toxicol 18:196–203
   PubMed Web of Science ®Google Scholar
• Hontecillas R, O'Shea M, Einerhand A, Diguardo M, Bassaganya-Riera J. 2009. Activation of PPAR gamma and alpha by punicic acid ameliorates glucose tolerance and suppresses obesity-related inflammation. J Am Coll Nutr 28:184–195
   PubMed Web of Science ®Google Scholar
• Huang ST, Wang CY, Yang RC, Wu HT, Yang SH, Cheng YC, Pang JH. 2011. Ellagic acid, the active compound of Phyllanthus urinaria, exerts in vivo anti-angiogenic effect and inhibits MMP-2 activity. Evid Based Complement Alternat Med 2011:215035
   PubMedGoogle Scholar
• Huang TH, Peng G, Kota BP, Li GQ, Yamahara J, Roufogalis BD, Li Y. 2005a. Anti-diabetic action of Punica granatum flower extract: activation of PPAR-gamma and identification of an active component. Toxicol Appl Pharmacol 207:160–169
   PubMed Web of Science ®Google Scholar
• Huang TH, Yang Q, Harada M, Li GQ, Yamahara J, Roufogalis BD, Li Y. 2005b. Pomegranate flower extract diminishes cardiac fibrosis in Zucker diabetic fatty rats: modulation of cardiac endothelin-1 and nuclear factor-kappaB pathways. J Cardiovasc Pharmacol 46:856–862
   PubMed Web of Science ®Google Scholar
• Iino T, Nakahara K, Miki W, Kiso Y, Ogawa Y, Kato S, Takeuchi K. 2001. Less damaging effect of whisky in rat stomachs in comparison with pure ethanol. Role of ellagic acid, the nonalcoholic component. Digestion 64:214–221
   PubMedGoogle Scholar
• Iino T, Tashima K, Umeda M, Ogawa Y, Takeeda M, Takata K, Takeuchi K. 2002. Effect of ellagic acid on gastric damage induced in ischemic rat stomachs following ammonia or reperfusion. Life Sci 70:1139–1150
   PubMed Web of Science ®Google Scholar
• Kannan MM, Quine SD. 2013. Ellagic acid inhibits cardiac arrhythmias, hypertrophy and hyperlipidaemia during myocardial infarction in rats. Metabolism 62:52–61
   PubMed Web of Science ®Google Scholar
• Karlsson S, Nånberg E, Fjaeraa C, Wijkander J. 2010. Ellagic acid inhibits lipopolysaccharide-induced expression of enzymes involved in the synthesis of prostaglandin E2 in human monocytes. Br J Nutr 103:1102–1109
   PubMed Web of Science ®Google Scholar
• Khanduja KL, Gandhi RK, Pathania V, Syal N. 1999. Prevention of N-nitrosodiethylamine-induced lung tumorigenesis by ellagic acid and quercetin in mice. Food Chem Toxicol 37:313–318
   PubMed Web of Science ®Google Scholar
• Khateeb J, Gantman A, Kreitenberg AJ, Aviram M, Fuhrman B. 2010. Paraoxonase 1 (PON1) expression in hepatocytes is upregulated by pomegranate polyphenols: a role for PPAR-gamma pathway. Atherosclerosis 208:119–125
   PubMed Web of Science ®Google Scholar
• Labrecque L, Lamy S, Chapus A, Mihoubi S, Durocher Y, Cass B, Bojanowski MW, et al. 2005. Combined inhibition of PDGF and VEGF receptors by ellagic acid, a dietary-derived phenolic compound. Carcinogenesis 26:821–826
   PubMed Web of Science ®Google Scholar
• Larrosa M, García-Conesa MT, Espín JC, Tomás-Barberán FA. 2010. Ellagitannins, ellagic acid and vascular health. Mol Aspects Med 31:513–539
   PubMed Web of Science ®Google Scholar
• Flavonoids and related compounds bioavailability and function. In: Spencer JPE, Crozier A, editors. Chapter 9. Bioavailability and metabolism of ellagic acid and ellagitannins. FL: CRC Press Taylor & Francis Group. p 183--196
   Google Scholar
• Lei F, Xing DM, Xiang L, Zhao YN, Wang W, Zhang LJ, Du LJ. 2003. Pharmacokinetic study of ellagic acid in rat after oral administration of pomegranate leaf extract. J Chromatogr B Analyt Technol Biomed Life Sci 796:189–194
   PubMed Web of Science ®Google Scholar
• Li TM, Chen GW, Su CC, Lin JG, Yeh CC, Cheng KC, Chung JG. 2005. Ellagic acid induced p53/p21 expression, G1 arrest and apoptosis in human bladder cancer T24 cells. Anticancer Res 25:971–979
   PubMed Web of Science ®Google Scholar
• Losso JN, Bansode RR, Trappey A, Bawadi HA, Truax R. 2004. In vitro anti-proliferative activities of ellagic acid. J Nutr Biochem 15:672–678
   PubMed Web of Science ®Google Scholar
• Malik A, Afaq F, Sarfaraz S, Adhami VM, Syed DN, Mukhtar H. 2005. Pomegranate fruit juice for chemoprevention and chemotherapy of prostate cancer. Proc Natl Acad Sci USA 102:14813–14818
   PubMed Web of Science ®Google Scholar
• Masamune A, Satoh M, Kikuta K, Suzuki N, Satoh K, Shimosegawa T. 2005. Ellagic acid blocks activation of pancreatic stellate cells. Biochem Pharmacol 70:869–878
   PubMed Web of Science ®Google Scholar
• Mattiello T, Trifirò E, Jotti GS, Pulcinelli FM. 2009. Effects of pomegranate juice and extract polyphenols on platelet function. J Med Food 12:334–339
   PubMedGoogle Scholar
• Mazumder A, Neamati N, Sunder S, Schulz J, Pertz H, Eich E, Pommier Y. 1997. Curcumin analogs with altered potencies against HIV-1 integrase as probes for biochemical mechanisms of drug action. J Med Chem 40:3057–3063
   PubMed Web of Science ®Google Scholar
• Mena P, Gironés-Vilaplana A, Moreno DA, García-Viguera C. 2011. Pomegranate fruit for health promotion: myths and realities. Funct Plant Sci Biotechnol 5:33–42
   Google Scholar
• Mertens-Talcott SU, Bomser JA, Romero C, Talcott ST, Percival SS. 2005. Ellagic acid potentiates the effect of quercetin on p21waf1/cip1, p53, and MAP-kinases without affecting intracellular generation of reactive oxygen species in vitro. J Nutr 135:609–614
   PubMed Web of Science ®Google Scholar
• Mertens-Talcott SU, Percival SS. 2005. Ellagic acid and quercetin interact synergistically with resveratrol in the induction of apoptosis and cause transient cell cycle arrest in human leukemia cells. Cancer Lett 218:141–151
   PubMed Web of Science ®Google Scholar
• Mishra S, Vinayak M. 2013. Ellagic acid checks lymphoma promotion via regulation of PKC signaling pathway. Mol Biol Rep 40:1417–1428
   PubMed Web of Science ®Google Scholar
• Mohan M, Waghulde H, Kasture S. 2010. Effect of pomegranate juice on Angiotensin II-induced hypertension in diabetic Wistar rats. Phytother Res 24:S196–S203
   Web of Science ®Google Scholar
• Murakami A, Nakamura Y, Koshimizu K, Takahashi D, Matsumoto K, Hagihara K, Taniguchi H, et al. 2002. FA15, a hydrophobic derivative of ferulic acid, suppresses inflammatory responses and skin tumor promotion: comparison with ferulic acid. Cancer Lett 180:121–129
   PubMed Web of Science ®Google Scholar
• Narayanan BA, Geoffroy O, Willingham MC, Re GG, Nixon DW. 1999. p53/p21(WAF1/CIP1) expression and its possible role in G1 arrest and apoptosis in ellagic acid treated cancer cells. Cancer Lett 136:215–221
   PubMed Web of Science ®Google Scholar
• Ojewole JA. 2006. Antiinflammatory and analgesic effects of Psidium guajava Linn. (Myrtaceae) leaf aqueous extract in rats and mice. Methods Find Exp Clin Pharmacol 28:441–446
   PubMed Web of Science ®Google Scholar
• Pantuck AJ, Leppert JT, Zomorodian N, Aronson W, Hong J, Barnard RJ, Seeram N, et al. 2006. Phase II study of pomegranate juice for men with rising prostate-specific antigen following surgery or radiation for prostate cancer. Clin Cancer Res 12:4018–4026
   PubMed Web of Science ®Google Scholar
• Papoutsi Z, Kassi E, Chinou I, Halabalaki M, Skaltsounis LA, Moutsatsou P. 2008. Walnut extract (Juglans regia L.) and its component ellagic acid exhibit anti-inflammatory activity in human aorta endothelial cells and osteoblastic activity in the cell line KS483. Br J Nutr 99:715–722
   PubMed Web of Science ®Google Scholar
• Priyadarsini KI, Khopde SM, Kumar SS, Mohan H. 2002. Free radical studies of ellagic acid, a natural phenolic antioxidant. J Agric Food Chem 50:2200–2206
   PubMed Web of Science ®Google Scholar
• Quideau S, Feldman KS. 1996. Ellagitannin chemistry. Chem Rev 96:475–504
   PubMed Web of Science ®Google Scholar
• Rocha A, Wang L, Penichet M, Martins-Green M. 2012. Pomegranate juice and specific components inhibit cell and molecular processes critical for metastasis of breast cancer. Breast Cancer Res Treat 136:647–658
   PubMed Web of Science ®Google Scholar
• Rogerio AP, Fontanari C, Melo MC, Ambrosio SR, de Souza GE, Pereira PS, França SC, et al. 2006. Anti-inflammatory, analgesic and anti-oedematous effects of Lafoensia pacari extract and ellagic acid. J Pharm Pharmacol 58:1265–1273
   PubMed Web of Science ®Google Scholar
• Rosenblat M, Volkova N, Aviram M. 2010. Pomegranate juice (PJ) consumption antioxidative properties on mouse macrophages, but not PJ beneficial effects on macrophage cholesterol and triglyceride metabolism, are mediated via PJ-induced stimulation of macrophage PON2. Atherosclerosis 212:86–92
   PubMed Web of Science ®Google Scholar
• Rosillo MA, Sánchez-Hidalgo M, Cárdeno A, Aparicio-Soto M, Sánchez-Fidalgo S, Villegas I, de la Lastra CA. 2012. Dietary supplementation of an ellagic acid-enriched pomegranate extract attenuates chronic colonic inflammation in rats. Pharmacol Res 66:235–242
   PubMed Web of Science ®Google Scholar
• Rukkumani R, Aruna K, Varma PS, Rajasekaran KN, Menon VP. 2004. Comparative effects of curcumin and an analog of curcumin on alcohol and PUFA induced oxidative stress. J Pharm Pharm Sci 7:274–283
   PubMed Web of Science ®Google Scholar
• Schubert SY, Lansky EP, Neeman I. 1999. Antioxidant and eicosanoid enzyme inhibition properties of pomegranate seed oil and fermented juice flavonoids. J Ethnopharmacol 66:11–17
   PubMed Web of Science ®Google Scholar
• Seeram NP, Lee R, Heber D. 2004. Bioavailability of ellagic acid in human plasma after consumption of ellagitannins from pomegranate (Punica granatum L.) juice. Clin Chim Acta 348:63–68
   PubMed Web of Science ®Google Scholar
• Sestili P, Martinelli C, Ricci D, Fraternale D, Bucchini A, Giamperi L, Curcio R, et al. 2007. Cytoprotective effect of preparations from various parts of Punica granatum L. fruits in oxidatively injured mammalian cells in comparison with their antioxidant capacity in cell free systems. Pharmacol Res 56:18–26
   PubMed Web of Science ®Google Scholar
• Shiner M, Fuhrman B, Aviram M. 2007. Macrophage paraoxonase 2 (PON2) expression is up-regulated by pomegranate juice phenolic anti-oxidants via PPAR gamma and AP-1 pathway activation. Atherosclerosis 195:313–321
   PubMed Web of Science ®Google Scholar
• Soni KB, Lahiri M, Chackradeo P, Bhide SV, Kuttan R. 1997. Protective effect of food additives on aflatoxin-induced mutagenicity and hepatocarcinogenicity. Cancer Lett 115:129–133
   PubMed Web of Science ®Google Scholar
• Strati A, Papoutsi Z, Lianidou E, Moutsatsou P. 2009. Effect of ellagic acid on the expression of human telomerase reverse transcriptase (hTERT) alpha+beta+ transcript in estrogen receptor-positive MCF-7 breast cancer cells. Clin Biochem 42:1358–1362
   PubMed Web of Science ®Google Scholar
• Sumner MD, Elliott-Eller M, Weidner G, Daubenmier JJ, Chew MH, Marlin R, Raisin CJ, Ornish D. 2005. Effects of pomegranate juice consumption on myocardial perfusion in patients with coronary heart disease. Am J Cardiol 96:810–814
   PubMed Web of Science ®Google Scholar
• Takahashi M, Yamashita A, Moriguchi-Goto S, Sugita C, Matsumoto T, Matsuda S, Sato Y, et al. 2010. Inhibition of factor XI reduces thrombus formation in rabbit jugular vein under endothelial denudation and/or blood stasis. Thromb Res 125:464–470
   PubMed Web of Science ®Google Scholar
• Teel RW. 1986. Ellagic acid binding to DNA as a possible mechanism for its antimutagenic and anticarcinogenic action. Cancer Lett 30:329–336
   PubMed Web of Science ®Google Scholar
• Thresiamma KC, George J, Kuttan R. 1998. Protective effect of curcumin, ellagic acid and bixin on radiation induced genotoxicity. J Exp Clin Cancer Res 17:431–434
   PubMed Web of Science ®Google Scholar
• Thresiamma KC, Kuttan R. 1996. Inhibition of liver fibrosis by ellagic acid. Indian J Physiol Pharmacol 40:363–366
   PubMedGoogle Scholar
• Tindle HA, Davis RB, Phillips RS, Eisenberg DM. 2005. Trends in use of complementary and alternative medicine by US adults: 1997–2002. Altern Ther Health Med 11:42–49
   PubMed Web of Science ®Google Scholar
• Umesalma S, Sudhandiran G. 2010. Differential inhibitory effects of the polyphenol ellagic acid on inflammatory mediators NF-kappaB, iNOS, COX-2, TNF-alpha, and IL-6 in 1,2-dimethylhydrazine-induced rat colon carcinogenesis. Basic Clin Pharmacol Toxicol 107:650–655
   PubMed Web of Science ®Google Scholar
• Umesalma S, Sudhandiran G. 2011. Ellagic acid prevents rat colon carcinogenesis induced by 1, 2 dimethyl hydrazine through inhibition of AKT-phosphoinositide-3 kinase pathway. Eur J Pharmacol 660:249–258
   PubMed Web of Science ®Google Scholar
• Wang L, Ho J, Glackin C, Martins-Green M. 2012. Specific pomegranate juice components as potential inhibitors of prostate cancer metastasis. Transl Oncol 5:344–355
   PubMed Web of Science ®Google Scholar
• Whitley AC, Stoner GD, Darby MV, Walle T. 2003. Intestinal epithelial cell accumulation of the cancer preventive polyphenol ellagic acid – extensive binding to protein and DNA. Biochem Pharmacol 66:907–915
   PubMed Web of Science ®Google Scholar
• Yılmaz B, Usta C. 2013. Ellagic acid-induced endothelium-dependent and endothelium-independent vasorelaxation in rat thoracic aortic rings and the underlying mechanism. Phytother Res 27:285–289
   PubMed Web of Science ®Google Scholar
• Yoshimura M, Watanabe Y, Kasai K, Yamakoshi J, Koga T. 2005. Inhibitory effect of an ellagic acid-rich pomegranate extract on tyrosinase activity and ultraviolet-induced pigmentation. Biosci Biotechnol Biochem 69:2368–2373
   PubMed Web of Science ®Google Scholar
• Yu YM, Chang WC, Wu CH, Chiang SY. 2005. Reduction of oxidative stress and apoptosis in hyperlipidemic rabbits by ellagic acid. J Nutr Biochem 16:675–681
   PubMed Web of Science ®Google Scholar
• Yu YM, Wang ZH, Liu CH, Chen CS. 2007. Ellagic acid inhibits IL-1beta-induced cell adhesion molecule expression in human umbilical vein endothelial cells. Br J Nutr 97:692–698
   PubMed Web of Science ®Google Scholar
• Zhang Z, Hamilton SM, Stewart C, Strother A, Teel RW. 1993. Inhibition of liver microsomal cytochrome P450 activity and metabolism of the tobacco-specific nitrosamine NNK by capsaicin and ellagic acid. Anticancer Res 13:2341–2346
   PubMed Web of Science ®Google Scholar